Growth hormone deficiency in a child with neurofibromatosis-noonan syndrome

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Neurofibromatosis-Noonan syndrome (NFNS) is a distinct entity which shows the features of both NF1 (neurofibromatosis 1) and Noonan syndrome (NS). While growth hormone deficiency (GHD) has been relatively frequently identified in NF1 and NS patients, there is limited experience in NFNS cases. The literature includes only one case report of a NFNS patient having GHD and that report primarily focuses on the dermatological lesions that accompany the syndrome and not on growth hormone (GH) treatment. Here, we present a 13-year-old girl who had clinical features of NFNS with a mutation in the NF1 gene. The case is the first NFNS patient reported in the literature who was diagnosed to have GHD and who received GH treatment until reaching final height. The findings in this patient show that short stature is a feature of NFNS and can be caused by GHD. Patients with NFNS who show poor growth should be evaluated for GHD.

Original languageEnglish
Pages (from-to)96-100
Number of pages5
JournalJCRPE Journal of Clinical Research in Pediatric Endocrinology
Volume8
Issue number1
DOIs
Publication statusPublished - Mar 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Growth hormone
  • Growth hormone deficiency
  • NF1 gene
  • Neurofibromatosis type 1
  • Neurofibromatosisnoonan syndrome
  • Noonan syndrome

Fingerprint

Dive into the research topics of 'Growth hormone deficiency in a child with neurofibromatosis-noonan syndrome'. Together they form a unique fingerprint.

Cite this